AVS makes the top of MD+DI’s list of Top 10 Private Medtech Companies to Watch in 2026!

AVS made the top of MD+DI's list of Top 10 Private Medtech Companies to Watch...

Read More

AVS Announces Positive Safety and Effectiveness Data in First 95 Patients Treated in Pulse IVL IDE Study

Nov. 5, 2025 - Principal Investigator, Dr. Chris Metzger, Interventional Cardiologist at Ballad Health in...

Read More

AVS Granted Innovation Award at ISET

AVS received the 2025 Innovation Award at the International Symposium on Endovascular Therapy (ISET), a...

Read More

AVS Completes a $36M Series B Financing Ahead of IVL U.S. Commercial Launch

BOSTON--(BUSINESS WIRE)--Amplitude Vascular Systems (AVS), a medical device company focused on safely and effectively treating...

Read More

AVS Enrolls First Patient in U.S. Pivotal Intravascular Lithotripsy Study

BOSTON--(BUSINESS WIRE)--Amplitude Vascular Systems (AVS), a medical device company focused on safely and effectively treating...

Read More

AVS Partners with the Jacobs Institute to Expedite Clinical Trials for Coronary and Carotid Indications

BOSTON--(BUSINESS WIRE)--Amplitude Vascular Systems (AVS), a medical device company focused on safely and effectively treating...

Read More

AVS Brings New Approach to Lithotripsy: Vanguards of Health Care

In a Vanguards of Health Care podcast episode, AVS CEO, Mark Toland sits down with...

Read More

Pulse IVL with Angie Volk & Sean Gilligan of AVS

Angie Volk, VP of Business Development at AVS, and Sean Gilligan, COO at AVS, recently...

Read More

AVS Receives IDE Approval from FDA for Pivotal Intravascular Lithotripsy Study

BOSTON--(BUSINESS WIRE)--Amplitude Vascular Systems (AVS), a medical device company focused on safely and effectively treating...

Read More